Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug shows promise against fatty liver disease in Mid-Stage trial

NCT ID NCT06108219

Ongoing Disease control Sponsor: Corcept Therapeutics Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug called miricorilant in 175 adults with nonalcoholic steatohepatitis (NASH), a serious fatty liver disease. Participants are randomly assigned to receive either the drug or a placebo, and researchers measure changes in liver fat using MRI scans over 24 to 48 weeks. The goal is to see if miricorilant can safely reduce liver fat and improve liver health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatohepatitis metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) NONALCOHOLIC STEATOHEPATITIS (NASH)

Contacts and locations

Locations

  • Site # 066

    Houston, Texas, 77030, United States

  • Site # 101

    Gainesville, Florida, 32610, United States

  • Site # 485

    Jaipur, Rajasthan, 302004, India

  • Site # 494

    Rohtak, Haryana, 124001, India

  • Site # 546

    Arlington, Texas, 76012, United States

  • Site #061

    Metairie, Louisiana, 70006, United States

  • Site #207

    Chandler, Arizona, 85224, United States

  • Site #209

    Tucson, Arizona, 85712, United States

  • Site #211

    Austin, Texas, 78757, United States

  • Site #212

    San Antonio, Texas, 78229, United States

  • Site #213

    Edinburg, Texas, 78539, United States

  • Site #214

    Panorama City, California, 91402, United States

  • Site #215

    Edinburg, Texas, 78539, United States

  • Site #226

    Seattle, Washington, 98105, United States

  • Site #228

    Kansas City, Missouri, 64131, United States

  • Site #233

    Santa Ana, California, 92704, United States

  • Site #305

    Houston, Texas, 77079, United States

  • Site #370

    Dallas, Texas, 75230, United States

  • Site #373

    Los Angeles, California, 90056, United States

  • Site #378

    Huntington Park, California, 90255, United States

  • Site #430

    Hialeah Gardens, Florida, 33016, United States

  • Site #431

    Georgetown, Texas, 78626, United States

  • Site #432

    Brownsville, Texas, 78520, United States

  • Site #433

    San Antonio, Texas, 78125, United States

  • Site #434

    Waco, Texas, 78125, United States

  • Site #437

    Westlake, Ohio, 44145, United States

  • Site #438

    Miami Lakes, Florida, 33016, United States

  • Site #439

    Lancaster, California, 93534, United States

  • Site #440

    Rockville, Maryland, 20854, United States

  • Site #441

    West Jordan, Utah, 84088, United States

  • Site #442

    Saint Paul, Minnesota, 55114, United States

  • Site #445

    East Syracuse, New York, 13057, United States

  • Site #447

    Beavercreek, Ohio, 45440, United States

  • Site #448

    Dayton, Ohio, 45145, United States

  • Site #451

    Marrero, Louisiana, 70072, United States

  • Site #452

    Boca Raton, Florida, 33434, United States

  • Site #453

    Houma, Louisiana, 70363, United States

  • Site #454

    New York, New York, 10033, United States

  • Site #455

    Jackson, New Jersey, 08724, United States

  • Site #457

    San Juan, 00927-4807, Puerto Rico

  • Site #458

    Lakewood Rch, Florida, 38018, United States

  • Site #459

    Katy, Texas, 77494, United States

  • Site #460

    Viera, Florida, 32940, United States

  • Site #461

    Cordova, Tennessee, 38018, United States

  • Site #463

    Manassas, Virginia, 20110, United States

  • Site #464

    Morehead City, North Carolina, 29557, United States

  • Site #465

    Hallandale, Florida, 33009, United States

  • Site #469

    Long Beach, California, 90815, United States

  • Site #470

    Columbus, Ohio, 43234, United States

  • Site #475

    Largo, Florida, 33777, United States

  • Site #482

    New Delhi, 110029, India

  • Site #486

    Hyderabad, Telangana, 500003, India

  • Site #487

    Kolkata, West Bengal, 700020, India

  • Site #488

    Varanasi, Uttar Pradesh, 221005, India

  • Site #489

    Jaipur, Rajasthan, 302001, India

  • Site #490

    Surat, Gujarat, 395009, India

  • Site #491

    Kolkata, West Bengal, 700150, India

  • Site #492

    Ahmedabad, Gujarat, 380053, India

  • Site #493

    Kolkata, West Bengal, 700073, India

  • Site #495

    Ludhiana, Punjab, 141002, India

  • Site #496

    Pune, Maharashtra, 412201, India

  • Site #500

    Nagpur, Maharashtra, 440009, India

  • Site #501

    New Delhi, 110070, India

  • Site #502

    Vadodara, Gujarat, 390007, India

  • Site #503

    Varanasi, Uttar Pradesh, 221005, India

  • Site #504

    Dehradun, Uttarakhand, 248001, India

  • Site #506

    Guwahati, Assam, 781032, India

  • Site #507

    Thiruvananthapuram, Kerala, 695011, India

  • Site #508

    Madurai, Tamil Nadu, 625020, India

  • Site #509

    Mumbai, Maharashtra, 400062, India

  • Site #510

    New Delhi, 110060, India

  • Site #511

    Mysore, Karnataka, 570015, India

  • Site #512

    Mumbai, Maharashtra, 400008, India

  • Site #513

    Rajkot, Gujarat, 360001, India

  • Site #514

    Surat, Gujarat, 395009, India

  • Site #545

    Austin, Texas, 78756, United States

  • Site #549

    Lucknow, Uttar Pradesh, 226003, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.